226 related articles for article (PubMed ID: 34133792)
1. TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury.
Zhou J; Hu M; He M; Wang X; Sun D; Huang Y; Cheng X; Fu J; Cai J; Ma T; Tian S; Hu Y; Hu F; Liu D; He Y; Yan L; She ZG; Zhang XJ; Ji YX; Liu H; Li H; Yang H; Zhang P
Hepatology; 2021 Oct; 74(4):2133-2153. PubMed ID: 34133792
[TBL] [Abstract][Full Text] [Related]
2. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury.
Liu Y; Lu T; Zhang C; Xu J; Xue Z; Busuttil RW; Xu N; Xia Q; Kupiec-Weglinski JW; Ji H
J Hepatol; 2019 Oct; 71(4):719-730. PubMed ID: 31201834
[TBL] [Abstract][Full Text] [Related]
3. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury.
Konishi T; Schuster RM; Lentsch AB
Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G471-G482. PubMed ID: 29351389
[TBL] [Abstract][Full Text] [Related]
4. TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation.
Liu D; Zhang P; Zhou J; Liao R; Che Y; Gao MM; Sun J; Cai J; Cheng X; Huang Y; Chen G; Nie H; Ji YX; Zhang XJ; Huang Z; Xu H; She ZG; Li H
Cell Metab; 2020 Apr; 31(4):726-740.e8. PubMed ID: 32268115
[TBL] [Abstract][Full Text] [Related]
5. JCAD deficiency delayed liver regenerative repair through the Hippo-YAP signalling pathway.
Zhang L; Yang YY; Xie L; Zhou Y; Zhong Z; Ding J; Wang ZH; Wang YL; Liu XP; Yu FX; Wu J
Clin Transl Med; 2024 Mar; 14(3):e1630. PubMed ID: 38509842
[TBL] [Abstract][Full Text] [Related]
6. Stress-Responsive Gene FK506-Binding Protein 51 Mediates Alcohol-Induced Liver Injury Through the Hippo Pathway and Chemokine (C-X-C Motif) Ligand 1 Signaling.
Kusumanchi P; Liang T; Zhang T; Ross RA; Han S; Chandler K; Oshodi A; Jiang Y; Dent AL; Skill NJ; Huda N; Ma J; Yang Z; Liangpunsakul S
Hepatology; 2021 Sep; 74(3):1234-1250. PubMed ID: 33710653
[TBL] [Abstract][Full Text] [Related]
7. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
8. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
[TBL] [Abstract][Full Text] [Related]
9. The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation.
Aylon Y; Gershoni A; Rotkopf R; Biton IE; Porat Z; Koh AP; Sun X; Lee Y; Fiel MI; Hoshida Y; Friedman SL; Johnson RL; Oren M
Genes Dev; 2016 Apr; 30(7):786-97. PubMed ID: 27013235
[TBL] [Abstract][Full Text] [Related]
10. Hippo (YAP)-autophagy axis protects against hepatic ischemia-reperfusion injury through JNK signaling.
Zhu S; Wang X; Chen H; Zhu W; Li X; Cui R; Yi X; Chen X; Li H; Wang G
Chin Med J (Engl); 2024 Mar; 137(6):657-668. PubMed ID: 37232477
[TBL] [Abstract][Full Text] [Related]
11. LATS2 condensates organize signalosomes for Hippo pathway signal transduction.
Qin M; Geng E; Wang J; Yu M; Dong T; Li S; Zhang X; Lin J; Shi M; Li J; Zhang H; Chen L; Cao X; Huang L; Wang M; Li Y; Yang XP; Zhao B; Sun S
Nat Chem Biol; 2024 Jun; 20(6):710-720. PubMed ID: 38200110
[TBL] [Abstract][Full Text] [Related]
12. Basic fibroblast growth factor protects against liver ischemia-reperfusion injury via the Nrf2/Hippo signaling pathway.
Chen X; Tong G; Chen S
Tissue Cell; 2022 Dec; 79():101921. PubMed ID: 36150335
[TBL] [Abstract][Full Text] [Related]
13. Hippo-YAP/MCP-1 mediated tubular maladaptive repair promote inflammation in renal failed recovery after ischemic AKI.
Zheng Z; Li C; Shao G; Li J; Xu K; Zhao Z; Zhang Z; Liu J; Wu H
Cell Death Dis; 2021 Jul; 12(8):754. PubMed ID: 34330891
[TBL] [Abstract][Full Text] [Related]
14. YAP-Dependent Induction of CD47-Enriched Extracellular Vesicles Inhibits Dendritic Cell Activation and Ameliorates Hepatic Ischemia-Reperfusion Injury.
Yuan Z; Ye L; Feng X; Zhou T; Zhou Y; Zhu S; Jia C; Li H; Qiu D; Li K; Liu W; Li Y; Tang H; Wang G; Zhang Q; Yang Y; Chen G; Li H
Oxid Med Cell Longev; 2021; 2021():6617345. PubMed ID: 34239692
[TBL] [Abstract][Full Text] [Related]
15. ARRB1 ameliorates liver ischaemia/reperfusion injury via antagonizing TRAF6-mediated Lysine 6-linked polyubiquitination of ASK1 in hepatocytes.
Xu X; Zhang Z; Lu Y; Sun Q; Liu Y; Liu Q; Tian W; Yin Y; Yu H; Sun B
J Cell Mol Med; 2020 Jul; 24(14):7814-7828. PubMed ID: 32445435
[TBL] [Abstract][Full Text] [Related]
16. Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.
Hu J; Zhu XH; Zhang XJ; Wang PX; Zhang R; Zhang P; Zhao GN; Gao L; Zhang XF; Tian S; Li H
J Hepatol; 2016 Jan; 64(1):146-59. PubMed ID: 26334576
[TBL] [Abstract][Full Text] [Related]
17. RASSF1A-Mediated Suppression of Estrogen Receptor Alpha (ERα)-Driven Breast Cancer Cell Growth Depends on the Hippo-Kinases LATS1 and 2.
Roßwag S; Sleeman JP; Thaler S
Cells; 2021 Oct; 10(11):. PubMed ID: 34831091
[TBL] [Abstract][Full Text] [Related]
18. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
[TBL] [Abstract][Full Text] [Related]
19. Multi-scale modeling of hippo signaling identifies homeostatic control by YAP-LATS negative feedback.
Sun T
Biosystems; 2021 Oct; 208():104475. PubMed ID: 34237349
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte-specific TMEM16A deficiency alleviates hepatic ischemia/reperfusion injury via suppressing GPX4-mediated ferroptosis.
Guo J; Song Z; Yu J; Li C; Jin C; Duan W; Liu X; Liu Y; Huang S; Tuo Y; Pei F; Jian Z; Zhou P; Zheng S; Zou Z; Zhang F; Gong Q; Liang S
Cell Death Dis; 2022 Dec; 13(12):1072. PubMed ID: 36572666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
